• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDOS INTERNATIONAL SARL DELTAPAQ CERE 1.5MMX6CM; NEUROVASCULAR EMBOLIZATION DEVICE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDOS INTERNATIONAL SARL DELTAPAQ CERE 1.5MMX6CM; NEUROVASCULAR EMBOLIZATION DEVICE Back to Search Results
Model Number CDF100156-30
Device Problem Failure to Advance (2524)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 04/13/2022
Event Type  malfunction  
Manufacturer Narrative
Manufacturer¿s ref.No: (b)(4).Information regarding patient identifier, date of birth, age, gender, weight, race, and ethnicity were not provided.The initial reporter phone: (b)(6).The initial reporter email address was not available / reported.[conclusion]: the healthcare professional reported that during an endovascular embolization procedure, the physician filled the target aneurysm with the first coil, a 2mm x 6cm deltaplush 10 cerecyte coil (cpl10020630 / s14489) and observed that it was impeded in the introducer.The physician adjusted the coil and pushed it out from the introducer, however, the coil was found to have unraveled / stretched.The physician used the second coil, another 2mm x 6cm deltaplush 10 cerecyte coil (cpl10020630 / s14489), but it was also impeded in the introducer and could not be pushed.A third coil, a 1.5mm x 6cm deltapaq 10 cerecyte coil (cdf10015630 / 30429053) was used but this coil also was impeded in the introducer and could not be pushed out.New devices were used to complete the procedure.There was no report of any patient adverse event or complication.The complaint device was returned for evaluation and analysis.The investigation finding is documented below.Investigation summary: a non-sterile 1.5mm x 6cm deltapaq 10 cerecyte coil was returned contained in the decontamination pouch.Visual inspection was performed.The embolic coil component was observed to be outside of the introducer.The core wire was observed protruding from the introducer.No other damage was observed.Microscopic inspection was performed.Under magnification, the embolic coil was observed to be stretched, but it still remains attached to the resistance heating (rh) coil.The introducer component was noted to be opened due to a kinked on it.The opened state of the introducer caused the core wire to become protruded in this area of the introducer.The impeded condition of the coil in the introducer as documented in the complaint could not be tested since the conditions in which the coil and the core wire were received prevented the advancement and retraction through the introducer.However, such conditions can be reasonably considered to be secondary to the issue encountered during the procedure.Coil stretching is a known potential issue associated with the use of this device.The instructions for use (ifu) provide proper handling instructions for the device to prevent such issues from occurring.Stretching can occur during procedure handling where force may have been inadvertently applied.The stretched condition of the embolic coil was not originally reported in the complaint.With the limited information available, the root cause of the coil stretching remains unknown.It is possible that a continuous flush had not been done, without an adequate flush, issue such as resistance between the coil and the introducer can arise, which may cause some force to be inadvertently exerted on the device, which can result in the coil becoming stretched.However, this cannot be conclusively determined.There is no indication that the issue reported in the complaint is a result of a defect inherently related to the device.The customer complaint was confirmed.A review of manufacturing documentation associated with this lot (30429053) presented no issues during the manufacturing or inspection processes related to the reported complaint.There were no nonconformances related to device manufacture or inspection.All product rejected during manufacturing was identified as scrap and properly accounted for.As part of the cerenovus quality process, all devices are manufactured, inspected, and released to approved specifications.It should be noted that product failure could be caused by multiple factors.The instructions for use (ifu) does contain the following recommendations: if repositioning of the microcoil is necessary, carefully observe the motion of the microcoil with respect to the dpu wire while retracting the microcoil under fluoroscopy.If the microcoil movement is not one-to-one with the dpu wire, or if repositioning is difficult, the microcoil may have become stretched and could possibly break.Gently remove and discard the microcoil system.If the microcoil is positioned at a relative sharp angle to the microcatheter, a microcoil may stretch or break as it is being withdrawn.By repositioning the distal tip of the microcatheter at or slightly inside the ostium (neck) of the aneurysm, the microcoil may be more easily funneled back into the microcatheter.If unusual friction is noticed during advancement or retraction of the microcoil system, verify the clear tab is unlocked and pulled out from the re-sheathing tool approximately 1 in.If unusual friction is still noticed during advancement or retraction of the microcoil system, verify flush lines are open and properly pressurized.Then slowly withdraw the entire microcoil system and examine for damage.Replace it with a new microcoil system.If friction still exists, withdraw, and examine the delivery catheter system.Based on the manufacturing documentation review, there is no indication that the event is related to the device manufacturing process.As part of the post market surveillance program, information from this complaint is trended for statistical signals and corrective / preventive action may be triggered at a later time.Since there was no evidence to suggest the event was related to a manufacturing or design issue, no corrective actions will be taken at this time.This is one of three (3) products involved with the reported complaint.The associated manufacturer report numbers are: 3008114965-2022-00294, 3008114965-2022-00527.Missing information from this report is identified as blank; this information was not provided in the reported event or available at the time of report submission.The manufacturer will submit a supplemental report if new facts arise which materially alter information submitted in a previous mdr report.Additional information will be submitted within 30 days of receipt.
 
Event Description
The healthcare professional reported that during an endovascular embolization procedure, the physician filled the target aneurysm with the first coil, a 2mm x 6cm deltaplush 10 cerecyte coil (cpl10020630 / s14489) and observed that it was impeded in the introducer.The physician adjusted the coil and pushed it out from the introducer, however, the coil was found to have unraveled / stretched.The physician used the second coil, another 2mm x 6cm deltaplush 10 cerecyte coil (cpl10020630 / s14489), but it was also impeded in the introducer and could not be pushed.A third coil, a 1.5mm x 6cm deltapaq 10 cerecyte coil (cdf10015630 / 30429053) was used but this coil also was impeded in the introducer and could not be pushed out.New devices were used to complete the procedure.There was no report of any patient adverse event or complication.The complaint device was returned for evaluation and analysis.Based on the result of the product analysis completed on 04-aug-2022, the event has been deemed reportable as a "malfunction.".
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
DELTAPAQ CERE 1.5MMX6CM
Type of Device
NEUROVASCULAR EMBOLIZATION DEVICE
Manufacturer (Section D)
MEDOS INTERNATIONAL SARL
chemin-blanc 38
le locle neuchatel CH-24 00
SZ  CH-2400
Manufacturer (Section G)
CODMAN & SHURTLEFF, INC. (FREMONT)
47709 fremont blvd
fremont CA 94538
Manufacturer Contact
michelleann garcia
31 technology dr
irvine, CA 92618
646591-798
MDR Report Key15170601
MDR Text Key297491586
Report Number3008114965-2022-00528
Device Sequence Number1
Product Code HCG
UDI-Device Identifier00878528007043
UDI-Public00878528007043
Combination Product (y/n)N
Reporter Country CodeCH
PMA/PMN Number
K080437
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 08/04/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberCDF100156-30
Device Catalogue NumberCDF10015630
Device Lot Number30429053
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer07/19/2022
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 08/04/2022
Initial Date FDA Received08/04/2022
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured09/03/2020
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-